Technical Analysis for MRNS - Marinus Pharmaceuticals, Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Up |
| Historical MRNS trend table... | |||
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| Fell Below 20 DMA | Bearish | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -14.35% | |
| Crossed Above 200 DMA | Bullish | -14.35% | |
| Crossed Above 20 DMA | Bullish | -14.35% | |
| Pocket Pivot | Bullish Swing Setup | -14.35% | |
| Wide Bands | Range Expansion | -14.35% | |
| Gapped Up | Strength | -14.35% | |
| Up 3 Days in a Row | Strength | -14.35% |
Get a Trading Sidekick!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/04/2020
- Sector: Healthcare
- Industry: Biotechnology
Marinus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on developing neuropsychiatric therapeutics. It offers Ganaxolone, a synthetic small molecule, which has completed Phase II clinical trial for the treatment of patients with refractory focal onset seizures; and is in proof-of-concept Phase II clinical trial as a treatment for behaviors in the orphan indication Fragile X Syndrome in children. The company has a collaboration agreement with NovaMedica, LLC, as well as a license agreement with Purdue Neuroscience Company. Marinus Pharmaceuticals, Inc. was founded in 2003 and is headquartered in New Haven, Connecticut.
Chemistry Physical Sciences Drugs Alcohols Ketones Pregnanes Sedatives Neurosteroids
Chemistry Physical Sciences Drugs Alcohols Ketones Pregnanes Sedatives Neurosteroids
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 3.5 |
| 52 Week Low | 1.01 |
| Average Volume | 1,680,004 |
| 200-Day Moving Average | 2.00 |
| 50-Day Moving Average | 2.28 |
| 20-Day Moving Average | 1.82 |
| 10-Day Moving Average | 1.74 |
| Average True Range | 0.20 |
| ADX | 20.21 |
| +DI | 26.36 |
| -DI | 19.03 |
| Chandelier Exit (Long, 3 ATRs ) | 2.02 |
| Chandelier Exit (Short, 3 ATRs ) | 2.11 |
| Upper Bollinger Band | 2.13 |
| Lower Bollinger Band | 1.51 |
| Percent B (%b) | 0.46 |
| BandWidth | 33.97 |
| MACD Line | -0.14 |
| MACD Signal Line | -0.18 |
| MACD Histogram | 0.0406 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 2.12 | ||||
| Resistance 3 (R3) | 2.15 | 2.08 | 2.07 | ||
| Resistance 2 (R2) | 2.08 | 1.99 | 2.06 | 2.05 | |
| Resistance 1 (R1) | 1.93 | 1.94 | 1.90 | 1.90 | 2.03 |
| Pivot Point | 1.86 | 1.86 | 1.84 | 1.84 | 1.86 |
| Support 1 (S1) | 1.71 | 1.77 | 1.68 | 1.68 | 1.55 |
| Support 2 (S2) | 1.64 | 1.72 | 1.62 | 1.53 | |
| Support 3 (S3) | 1.49 | 1.64 | 1.52 | ||
| Support 4 (S4) | 1.46 |
